Jmc. Greiff et D. Rowbotham, PHARMACOKINETIC DRUG-INTERACTIONS WITH GASTROINTESTINAL MOTILITY MODIFYING AGENTS, Clinical pharmacokinetics, 27(6), 1994, pp. 447-461
Drugs may affect gastrointestinal motility and, therefore, absorption
of other concomitantly administered drugs. Gastrointestinal prokinetic
agents increase the rate of gastric emptying and also upper intestina
l motility. These effects would be expected to increase the initial ra
te of absorption of orally administered drugs, but reduce total bioava
ilability of the agents. Metoclopramide has been shown to increase the
rate of absorption of several classes of drug, reflected by reduced t
ime taken to achieve maximal plasma concentration (t(max)) and increas
ed maximal plasma concentration (C-max). However, the effect of these
agents on the area under the plasma concentration-time curve from zero
to infinity (AUC(0-infinity)), when measured. is not consistent. Cisa
pride and domperidone appear to have similar effects. but there are re
latively less data available regarding these products. Opioids may del
ay gastric emptying considerably, an effect which will often have sign
ificant clinical and therapeutic implications, Most of the data confir
ming this observation concern oral analgesics, but the effect should b
e considered when prescribing any oral medication. Drugs with antichol
inergic or sympathomimetic activity are likely to have a similar effec
t and this is confirmed, in the main, by the limited data available. A
lthough many effects reported in the literature are of limited clinica
l importance, they may be significant when prescribing a drug with a n
arrow therapeutic index. especially if it is absorbed poorly.